Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Zinc deficiency drives ferroptosis resistance by lactate production in esophageal squamous cell carcinoma.

Free radical biology & medicine·2024

Same author

A critical review of advances in tumor metabolism abnormalities induced by nitrosamine disinfection by-products in drinking water.

Toxicological sciences : an official journal of the Society of Toxicology·2024

Same author

YY1 is a transcriptional activator of mouse LINE-1 Tf subfamily.

bioRxiv : the preprint server for biology·2024

Same author

The application of lightweight AI algorithms in postoperative rehabilitation of breast cancer.

Computer methods in biomechanics and biomedical engineering·2023

Same author

The Diagnostic Value of Serum TGF-β1, p2PSA Combined with PSA in Prostate Cancer.

Alternative therapies in health and medicine·2023

Same author

Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial.

The Journal of allergy and clinical immunology·2023

Search research articles

Related Experiment Video

Updated: May 12, 2026

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

High-sensitive cardiac troponin T.

Ru-Yi Xu¹, Xiao-Fa Zhu, Ye Yang

¹Department of Geriatric Cardiology, Navy General Hospital, No.6, Fucheng Road, Beijing 100048, China.

Journal of Geriatric Cardiology : JGC

|April 24, 2013

Summary

High-sensitive cardiac troponin T (hs-cTnT) assays improve acute myocardial infarction diagnosis. While more sensitive, hs-cTnT requires careful interpretation alongside clinical context due to lower specificity.

Keywords:

Acute myocardial infarction Risk stratification Troponin T

More Related Videos

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Related Experiment Videos

Last Updated: May 12, 2026

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Area of Science:

Cardiology
Biomarkers
Diagnostic Medicine

Background:

Cardiac troponin is a key biomarker for diagnosing acute myocardial infarction (AMI).
Traditional assays have limitations in detecting subtle cardiac muscle damage.
Advancements in assay technology are crucial for improving diagnostic capabilities.

Purpose of the Study:

To evaluate the diagnostic performance of a high-sensitive cardiac troponin T (hs-cTnT) assay.
To assess the prognostic value of hs-cTnT in various cardiovascular conditions.
To understand the implications of increased sensitivity on diagnostic specificity.

Main Methods:

Utilized a high-sensitive cardiac troponin T (hs-cTnT) assay for biomarker measurement.
Analyzed diagnostic accuracy and negative predictive value in suspected AMI cases.
Examined prognostic information across patient cohorts including acute coronary syndromes, heart failure, and stable coronary artery disease.

Main Results:

The hs-cTnT assay enhances diagnostic accuracy for AMI, especially in early presentation.
A negative hs-cTnT result demonstrates a high negative predictive value.
Increased sensitivity of hs-cTnT is associated with decreased specificity, necessitating careful interpretation.

Conclusions:

hs-cTnT assays offer improved sensitivity for AMI diagnosis and prognostic insights.
The clinical utility of hs-cTnT is maximized when interpreted within the broader clinical context.
Serial testing and consideration of comorbidities are essential for accurate hs-cTnT interpretation.